{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:29:26Z","timestamp":1790260166000,"version":"4.1.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00043","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:47:45Z","timestamp":1519606065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report"],"prefix":"10.3389","volume":"8","author":[{"given":"Guna","family":"Proboka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra","family":"Tilgase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergejs","family":"Isajevs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnija","family":"Rasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0113teris","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/apm.12576","article-title":"Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports","volume":"124","author":"Alberts","year":"2016","journal-title":"APMIS"},{"key":"B2","first-page":"572","article-title":"Survival rates of patients with metastatic malignant melanoma","volume":"7","author":"Sandru","year":"2014","journal-title":"J Med Life"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1200\/jco.2008.18.9845","article-title":"Improved survival for stage IV melanoma from an unknown primary site","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaad.2014.09.029","article-title":"Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies","volume":"72","author":"Bae","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13256-017-1238-y","article-title":"The undifferentiated carcinoma that became a melanoma: re-biopsy of a cancer of an unknown primary site: a case report","volume":"11","author":"R\u00f8e","year":"2017","journal-title":"J Med Case Reports"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/neuonc\/nov093","article-title":"Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases","volume":"17","author":"Patel","year":"2015","journal-title":"Neuro Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/ijms17091468","article-title":"Melanoma brain metastasis: mechanisms, models, and medicine","volume":"17","author":"Kircher","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.virol.2010.12.014","article-title":"Enterovirus infections of the central nervous system review","volume":"411","author":"Rhoades","year":"2011","journal-title":"Virology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coi.2015.10.008","article-title":"Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier","volume":"38","author":"Miner","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/187221108783331429","article-title":"Recent patents review on intranasal administration for CNS drug delivery","volume":"2","author":"Jogani","year":"2008","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/mt.2013.199","article-title":"Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors","volume":"22","author":"Balyasnikova","year":"2014","journal-title":"Mol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.stemcr.2016.07.024","article-title":"Intranasal oncolytic virotherapy with CXCR4-enhanced stem cells extends survival in mouse model of glioma","volume":"7","author":"Dey","year":"2016","journal-title":"Stem Cell Reports"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2018.1378642","article-title":"Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies","volume":"15","author":"Li","year":"2018","journal-title":"Expert Opin Drug Deliv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/bjc.2017.142","article-title":"Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases","volume":"116","author":"Parakh","year":"2017","journal-title":"Br J Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/CMR.0000000000000180","article-title":"Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study","volume":"25","author":"Doni\u0146a","year":"2015","journal-title":"Melanoma Res"}],"updated-by":[{"DOI":"10.3389\/fonc.2018.00172","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T02:01:58Z","timestamp":1526608918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":16,"alternative-id":["10.3389\/fonc.2018.00043"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00043","relation":{"erratum":[{"id-type":"doi","id":"10.3389\/fonc.2018.00172","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"article-number":"43"}}